About 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide
2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide (PubChem CID 19324063) has the molecular formula C25H29BrClF3N6O3
and a molecular weight of 633.90 g/mol. Its IUPAC name is 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide.
Molecular Properties
| Compound Name | 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide |
| PubChem CID | 19324063 |
| Molecular Formula | C25H29BrClF3N6O3 |
| Molecular Weight | 633.90 g/mol |
| Exact Mass | 632.11 |
| IUPAC Name | 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide |
| SMILES | O=C(CC12CC3CC(C1)CC(n1cc(Br)c([N+](=O)[O-])n1)(C3)C2)NCCCn1nc(C(F)(F)F)c(Cl)c1C1CC1 |
| InChI | InChI=1S/C25H29BrClF3N6O3/c26-17-12-35(33-22(17)36(38)39)24-9-14-6-15(10-24)8-23(7-14,13-24)11-18(37)31-4-1-5-34-20(16-2-3-16)19(27)21(32-34)25(28,29)30/h12,14-16H,1-11,13H2,(H,31,37) |
| InChIKey | SDBVJYIOUXPYMJ-UHFFFAOYSA-N |
| XLogP | 6.19 |
| TPSA | 107.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 633.90 |
| LogP ≤ 5 | 6.19 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide?
The IUPAC name of 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide (CID 19324063) is 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide.
What is the SMILES notation for 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide?
The canonical SMILES for 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide is O=C(CC12CC3CC(C1)CC(n1cc(Br)c([N+](=O)[O-])n1)(C3)C2)NCCCn1nc(C(F)(F)F)c(Cl)c1C1CC1.
What is the InChIKey of 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide?
The InChIKey is SDBVJYIOUXPYMJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29BrClF3N6O3/c26-17-12-35(33-22(17)36(38)39)24-9-14-6-15(10-24)8-23(7-14,13-24)11-18(37)31-4-1-5-34-20(16-2-3-16)19(27)21(32-34)25(28,29)30/h12,14-16H,1-11,13H2,(H,31,37).
What are the key properties of 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide?
2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide has a molecular weight of 633.90 g/mol, XLogP of 6.19, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(4-bromo-3-nitropyrazol-1-yl)-1-adamantyl]-N-[3-[4-chloro-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propyl]acetamide is sourced from PubChem (CID 19324063), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).